MPTP Parkinsonism and Implications for Understanding Parkinson's Disease.
作者信息
AlShimemeri Sohaila, Di Luca Daniel G, Fox Susan H
机构信息
The Edmond J. Safra Program in Parkinson Disease, Toronto Western Hospital Toronto Ontario Canada.
Krembil Brain Institute, University Health Network Toronto Ontario Canada.
出版信息
Mov Disord Clin Pract. 2021 Sep 25;9(1):42-47. doi: 10.1002/mdc3.13344. eCollection 2022 Jan.
Abstract
摘要
相似文献
1
MPTP Parkinsonism and Implications for Understanding Parkinson's Disease.MPTP诱导的帕金森综合征及其对理解帕金森病的意义
Mov Disord Clin Pract. 2021 Sep 25;9(1):42-47. doi: 10.1002/mdc3.13344. eCollection 2022 Jan.
2
Neurotoxicity of MPTP.1-甲基-4-苯基-1,2,3,6-四氢吡啶（MPTP）的神经毒性
Neuropathology. 2001 Dec;21(4):323-32. doi: 10.1046/j.1440-1789.2001.00402.x.
3
The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).纹状体多巴胺缺乏的临床综合征。1-甲基-4-苯基-1,2,3,6-四氢吡啶（MPTP）诱发的帕金森综合征。
N Engl J Med. 1985 May 30;312(22):1418-21. doi: 10.1056/NEJM198505303122203.
4
Suspected MPTP-induced parkinsonism.疑似MPTP诱导的帕金森症。
J Clin Neurosci. 1997 Jul;4(3):366-70. doi: 10.1016/s0967-5868(97)90110-7.
5
MPTP-induced parkinsonism as a model for Parkinson's disease.MPTP诱导的帕金森综合征作为帕金森病的一种模型
Acta Neurol Scand Suppl. 1989;126:35-40. doi: 10.1111/j.1600-0404.1989.tb01780.x.
6
Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus).长期重度1-甲基-4-苯基-1,2,3,6-四氢吡啶诱导黑长尾猴（Cercopithecus aethiops sabaeus）患帕金森病。
Neuroscience. 1997 Dec;81(3):745-55. doi: 10.1016/s0306-4522(97)00214-5.
7
Animal models of parkinsonism.帕金森病动物模型。
Pharmacol Toxicol. 1990 Aug;67(2):95-100. doi: 10.1111/j.1600-0773.1990.tb00792.x.
8
Similarity and dissimilarity of MPTP models to Parkinson's disease: importance of juvenile parkinsonism.MPTP模型与帕金森病的异同：青少年帕金森病的重要性。
Eur Neurol. 1987;26 Suppl 1:24-9. doi: 10.1159/000116352.
9
A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease.内源性大麻素在帕金森病的MPTP损伤非人灵长类动物模型中帕金森综合征及左旋多巴诱发的运动障碍产生中的作用。
FASEB J. 2005 Jul;19(9):1140-2. doi: 10.1096/fj.04-3010fje. Epub 2005 May 13.
10
Translocator Protein Ligand Protects against Neurodegeneration in the MPTP Mouse Model of Parkinsonism.转位蛋白配体可预防 MPTP 帕金森病小鼠模型的神经退行性变。
J Neurosci. 2019 May 8;39(19):3752-3769. doi: 10.1523/JNEUROSCI.2070-18.2019. Epub 2019 Feb 22.
引用本文的文献
1
Ameliorative role of naringenin in MPTP- induced Parkinsonism: Insights from experimental model combined with computational biology.柚皮素在MPTP诱导的帕金森病中的改善作用：来自实验模型与计算生物学的见解
Toxicol Rep. 2025 Mar 20;14:102004. doi: 10.1016/j.toxrep.2025.102004. eCollection 2025 Jun.
2
Vitamin B12 Ameliorates the Pathological Phenotypes of Multiple Parkinson's Disease Models by Alleviating Oxidative Stress.维生素B12通过减轻氧化应激改善多种帕金森病模型的病理表型。
Antioxidants (Basel). 2023 Jan 9;12(1):153. doi: 10.3390/antiox12010153.
3
Lycium barbarum polysaccharide improves dopamine metabolism and symptoms in an MPTP-induced model of Parkinson's disease.枸杞多糖改善 MPTP 诱导的帕金森病模型中的多巴胺代谢和症状。
BMC Med. 2022 Oct 28;20(1):412. doi: 10.1186/s12916-022-02621-9.
本文引用的文献
1
Breathing new life into neurotoxic-based monkey models of Parkinson's disease to study the complex biological interplay between serotonin and dopamine.为研究血清素和多巴胺之间复杂的生物学相互作用，给神经毒性帕金森病猴模型注入新活力。
Prog Brain Res. 2021;261:265-285. doi: 10.1016/bs.pbr.2020.07.015. Epub 2020 Aug 18.
2
Is there a special relationship between complex I activity and nigral neuronal loss in Parkinson's disease? A critical reappraisal.在帕金森病中，复合物 I 活性与黑质神经元丧失之间是否存在特殊关系？批判性再评价。
Brain Res. 2021 Sep 15;1767:147434. doi: 10.1016/j.brainres.2021.147434. Epub 2021 Mar 19.
3
SARS-CoV-2 and the risk of Parkinson's disease: facts and fantasy.严重急性呼吸综合征冠状病毒2与帕金森病风险：事实与幻想
Lancet Neurol. 2021 Feb;20(2):94-95. doi: 10.1016/S1474-4422(20)30442-7. Epub 2020 Nov 27.
4
From iPS Cells to Rodents and Nonhuman Primates: Filling Gaps in Modeling Parkinson's Disease.从诱导多能干细胞到啮齿动物和非人类灵长类动物：填补帕金森病模型的空白。
Mov Disord. 2021 Apr;36(4):832-841. doi: 10.1002/mds.28387. Epub 2020 Nov 16.
5
The MPTP-lesioned marmoset model of Parkinson's disease: proposed efficacy thresholds that may potentially predict successful clinical trial results.MPTP 损毁恒河猴帕金森病模型：可能预测临床试验成功的潜在疗效阈值。
J Neural Transm (Vienna). 2020 Oct;127(10):1343-1358. doi: 10.1007/s00702-020-02247-2. Epub 2020 Aug 29.
6
GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop.GDNF 与帕金森病：未来之路？近期研讨会总结。
J Parkinsons Dis. 2020;10(3):875-891. doi: 10.3233/JPD-202004.
7
Parkinson's Disease in Women and Men: What's the Difference?帕金森病在男性和女性中的表现有何不同？
J Parkinsons Dis. 2019;9(3):501-515. doi: 10.3233/JPD-191683.
8
The USA lags behind other agricultural nations in banning harmful pesticides.美国在禁止有害农药方面落后于其他农业国家。
Environ Health. 2019 Jun 7;18(1):44. doi: 10.1186/s12940-019-0488-0.
9
International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease.国际帕金森病和运动障碍学会循证医学综述：帕金森病运动症状治疗的最新进展。
Mov Disord. 2018 Aug;33(8):1248-1266. doi: 10.1002/mds.27372. Epub 2018 Mar 23.
10
Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.慢性 MPTP 给药方案在猴子中的应用：帕金森病多巴胺能和非多巴胺能细胞丧失的模型。
J Neural Transm (Vienna). 2018 Mar;125(3):337-363. doi: 10.1007/s00702-017-1774-z. Epub 2017 Aug 31.
Zotero 插件